Skip to main content
Clinical Trials/JPRN-UMIN000009040
JPRN-UMIN000009040Completed未知

A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients with moderate to severe disease activities and healthy adults - A study of expression levels of the interferon regulated genes in Japanese systemic lupus erythematosus patients

Chugai Pharmaceutical co., ltd.0 sites110 target enrollmentStarted: October 4, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
110

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to 65years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (ERL/LN) -Unstable neuropsychiatric SLE at the time of sampling. -Evidence of significant uncontrolled concomitant diseases (e.g., cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine, or gastrointestinal disorders) at the time of sampling. -Conditions other than SLE that could require treatment with corticosteroids (e.g., asthma) at the time of within 12 months prior to sampling. -History of cancer within 5 years prior to sampling. -History of congenital immunodeficiency. -Signs or symptoms of infection within 31 days prior to sampling (Healthy adults) -Evidence of concomitant diseases (e.g., cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine, or gastrointestinal disorders) at the time of sampling. -History of cancer within 5 years prior to sampling. -Any clinically abnormal conditions at the time of sampling. -Signs or symptoms of infection within 31 days prior to sampling.

Investigators

Similar Trials